phenotype severity in Scn1a +/− mice have been reported. [7] [8] [9] [10] [11] Scn1a +/− mice on the 129S6/SvEvTac (129S6) strain have no overt phenotype. When crossed with C57BL/6J, resulting F1.Scn1a +/− mice have a severe phenotype with spontaneous seizures and premature lethality. 8 Genetic analysis revealed several responsible modifier loci and genes, including Gabra2, Cacna1g, and Hlf. 7, 8, 12, 13 The effect of the C57BL/6 substrain on phenotype expressivity in Scn1a +/− mice has not been systematically evaluated, although C57BL/6 substrain differences in susceptibility to induced seizures have been documented. [14] [15] [16] In the current study, we compared seizure susceptibility, spontaneous seizures, and survival in Scn1a
+/− mice with B6J vs B6N alleles. Several differences were detected, with B6N alleles associated with reduced severity of spontaneous seizures and improved survival. Our results suggest that these strains carry differential modifier alleles that alter phenotype severity in the context of Scn1a heterozygous deletion, and emphasize the importance of substrain selection in experimental design and interpretation. 
| MATERIALS AND METHODS

| Mice
| Hyperthermia-induced seizure thresholds
On P18, mice underwent a hyperthermia-induced seizure threshold assay as described previously. 9 Core body temperatures at baseline, and at onset of myoclonic and generalized tonic-clonic seizures (GTCS) were recorded. 
F1N.Scn1a
+/− mice. Lower group size relative to the hyperthermia assay was due to technical issues (video record corruption and rapid cooling failure). GTCS events (forelimb clonus with rearing/loss-of-posture) and severity (with or without tonic hindlimb extension at a 180 degrees relative to torso) were scored by reviewers blinded to the groups as described. 9 Following cessation of recording, mice were monitored for short-term survival until P30.
| Extended survival monitoring
A separate cohort of mice weaned at P18-20 into standard vivarium cages with 4-5 sex-and age-matched mice was monitored for survival until P60. Daily health surveillance was conducted and any mouse exhibiting signs of unexpected morbidity was euthanized and excluded from the study.
| Statistics
Statistical analyses were conducted using Prism 7 software (GraphPad Inc., La Jolla, California). Between-group comparisons for survival and temperature thresholds for hyperthermia-induced seizures were conducted using timeto-event analysis with P-values determined with LogRank Mantel-Cox tests. Events occurring after predetermined cutoffs were censored (P30 or P60 for survival; 42.5°C for hyperthermia GTCS threshold). Spontaneous seizure frequencies and GTCS temperature thresholds were compared by Mann-Whitney U tests. Within-genotype comparisons between sexes indicated no differences, therefore groups were collapsed across sex. Data are presented as median or mean ± standard error of the mean (SEM) and P < 0.05 was considered statistically significant. Although there were no differences in seizure incidence or frequency, there was a difference in the proportion of GTCS advancing to the most severe stage of tonic hindlimb extension (hindlimbs at 180 degrees to the torso). In F1J.Scn1a +/− mice, 57 ± 13% of seizures advanced to tonic hindlimb extension compared to only 24 ± 8% in F1N.Scn1a +/− mice ( Figure 2B ; P < 0.031; unpaired t test). The proportion of GTCS advancing to tonic hindlimb extension in F1J.Scn1a +/− mice was similar to that of previous reports. 9 Following video recording, this cohort was monitored for short-term survival to 30 days of age. Only 44% of F1J.Scn1a +/− mice survived to P30 compared to 80% of F1N.Scn1a +/− mice ( Figure 2C ; P < 0.023; LogRank Mantel-Cox). All recorded deaths followed a hindlimb extension seizure in video records, although not all hindlimb extension seizures led to death. There was no relationship between hyperthermia-induced GTCS threshold and subsequent seizure frequency or survival (R 2 < 0.008 for F1J and R 2 < 0.133 for F1N).
To further evaluate the survival difference, we performed an extended survival study on a separate cohort of naive F1J.Scn1a +/− and F1N.Scn1a +/− mice that were not subjected to hyperthermia. F1N.Scn1a +/− mice had better survival, with 69% (22/32) surviving to P60, compared to 42% (13/31) of F1J.Scn1a +/− mice ( Figure 2D ; P < 0.032; LogRank MantelCox). Consistent with our previous observations, 9,17 induction of a GTCS by hyperthermia at P18 accelerated lethality in F1J.Scn1a
, with P30 survival of 44% following hyperthermia priming compared to P30 survival of 65% without 
| DISCUSSION
In this study, we observed strain-dependent phenotype variability in F1N.Scn1a +/− compared to F1J.Scn1a +/− mice, including differences in hyperthermia-induced seizure thresholds, spontaneous seizure severity, and survival. Seizures with tonic hindlimb extension involve brainstem, a critical component of the autonomic nervous system that modulates cardiovascular and respiratory function. 18 Despite unaltered seizure frequency in F1N.Scn1a +/− compared to F1J.Scn1a +/− mice, the lower proportion of GTCS advancing to tonic hindlimb extension in F1N.Scn1a +/− mice may contribute to improved survival. This is consistent with our previous observations that poor survival of Scn1a +/− mice is more strongly associated with occurrence of tonic hindlimb extension than overall GTCS frequency.
9
F1N.Scn1a +/− mice had a lower temperature threshold for myoclonic and GTCS compared to F1J.Scn1a +/− mice. This is consistent with previous studies that showed lower flurothylinduced myoclonic and GTCS thresholds for C57BL/6N vs C57BL/6J mice, whereas repeated seizure inductions were more likely to progress rapidly from forebrain to brainstem seizures in C57BL/6J than other B6 substrains or DBA. 15 The propensity of C57BL/6J mice to quickly progress to brainstem seizures may contribute to the elevated mortality risk in Scn1a +/− mice with C57BL/6J alleles.
In addition to differences in seizure susceptibility and variable expressivity of epilepsy in different C57BL/6 substrains, there are also reported differences among mice of the same substrain from different vendors. Differential phenotype severity was reported preliminarily in Scn1a +/− offspring resulting from crosses with C57BL/6 sourced from Charles River vs Jackson Laboratories. 19 missense variant (rs240617401) in Cyfip2 that results in lossof-function and was associated with altered cocaine-response phenotypes in C57BL/6NJ vs C57BL/6J. 22 It is possible that S968F may also influence excitation/inhibition balance. Jmjd1c encodes a putative histone demethylase. Sáez et al 23 reported heterozygous de novo variants in JMJD1C in 2 unrelated individuals with Rett syndrome and showed reduced dendritic complexity with small interfering RNA knockdown in mouse hippocampal neurons. C57BL/6J codes for a leucine at position 1715, whereas C57BL/6NJ and other strains have a proline in this position (rs13480628), although the effect on protein function is predicted to be benign. 24, 25 Additional genetic and functional evidence is required for formal candidate gene consideration. Effects of genetic background on disease phenotypes are often underestimated. This study adds to mounting evidence that C57BL/6 substrains harbor modifier alleles that must be carefully taken into account for experimental design and data interpretation.
